The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Soligenix, Inc(NASDAQ:SNGX) 
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301, a no...
Website: http://www.soligenix.com
Founded: 1987
Full Time Employees: 15
Sector: Healthcare
Industry: Biotechnology
Soligenix Days Payable Outstanding ttm (DPO)
Soligenix Days Receivable Outstanding ttm (DSO)
Soligenix Op Cashflow Per Share ttm
Soligenix Free Cashflow Per Share ttm
Soligenix Cash Per Share ttm
Soligenix P/S ratio ttm
Soligenix (GAAP) P/E ratio ttm
Soligenix P/B ratio ttm
No extra charts and metrics for this ticker.